Page last updated: 2024-08-16

salmeterol xinafoate and Dyspnea

salmeterol xinafoate has been researched along with Dyspnea in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (7.69)	18.2507
2000's	24 (61.54)	29.6817
2010's	11 (28.21)	24.3611
2020's	1 (2.56)	2.80

Authors

Authors	Studies
Agarwal, J; Compton, C; Czira, A; Dong, X; Duarte, M; Haeussler, K; Halpin, DMG; Ismaila, AS; Malmenäs, M; Nassim, M; Shen, Y; Tongbram, V; Vogelmeier, CF; Živković-Gojović, M	1
Cao, W; Decuypère, L; Devouassoux, G; Girodet, PO; Jasnot, JY; Le Gros, V	1
Li, Z; Tian, C; Wang, L; Wang, X	1
Connolly, MJ; Hanania, NA; Yohannes, AM	1
Duiverman, AE; Hop, WC; Jongste, JC; Nuijsink, M; Sterk, PJ	1
Dekhuijzen, PN; Heijdra, YF; Hop, WC; Ramlal, SK; Visser, FJ	1
Cockle, SM; Huisman, EL; Ismaila, AS; Karabis, A; Punekar, YS	1
Auciello, L; Biscione, G; Cazzola, M; Crigna, G; Pasqua, F	1
Aumann, JL; Cornelissen, PJ; Janssens, E; Mueller, A; Smeets, JJ; van Noord, JA; Zaagsma, J	1
Centanni, S; Dahl, R; Dogra, A; Kornmann, O; Kramer, B; Lassen, C; Owen, R	1
Gale, R; Jones, PW; Kramer, B; Mahler, DA; Owen, R	1
Dahl, R; Decramer, M; Korn, S; Kornmann, O; Lawrence, D; McBryan, D	1
Sanjuás, C	1
Fraser, J	1
Boveri, B; Carlucci, P; Casanova, F; Cazzola, M; Centanni, S; Di Marco, F; Milic-Emili, J; Santus, P	1
Mahler, DA; Witek, TJ	1
Brusasco, V; Hodder, R; Kesten, S; Korducki, L; Miravitlles, M; Towse, L	1
Beckerman, M; Berar-Yanay, N; Magadle, R; Weiner, P	1
Aguilaniu, B	1
Calverley, PM	1
Donohue, JF; Emmett, A; Kalberg, C; Knobil, K; Merchant, K	1
Aalbers, R; Politiek, MJ; Postma, DS; van der Woude, HJ; Winter, TH	1
Anderson, JA; Calverley, P; Jones, P; Pauwels, R; Vestbo, J	1
Chopra, N; Rice, L; Stockley, RA	1
Chorostowska-Wynimko, J	1
Rabe, KF	1
Allegra, L; Brown, RA; Cazzola, M; Matera, MG; Page, CP	1
Celli, B; Kalberg, CJ; Knobil, K; Mahler, DA; O'Donnell, DE; Sciurba, F; Webb, KA	1
Tashkin, DP	1
Baumgartner, RA; Calhoun, WJ; Hanania, NA; Hanrahan, JP; Sahn, SA; Sciarappa, K	1
Hodder, R; Kesten, S; Menjoge, S; Viel, K	1
Brouillard, C; Lacasse, Y; Maltais, F; Milot, J; Pepin, V	1
Bertella, E; Boni, E; Corda, L; La Piana, GE; Redolfi, S; Tantucci, C	1
Lentine, T; Mahler, DA; Ramirez-Venegas, A; Ward, J	1
Słomka, A	1
Jones, PW	1
Berar-Yanay, N; Davidovich, A; Magadle, R; Weiner, M; Weiner, P	1
Ayers, ML; Lentine, T; Mahler, DA; Mejia, R; Ward, J	1
Aalbers, R; van der Woude, HJ	1

Reviews

8 review(s) available for salmeterol xinafoate and Dyspnea

Article	Year
Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis. Advances in therapy, 2022, Volume: 39, Issue:11 Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Drug Combinations; Dyspnea; Forced Expiratory Volume; Glycopyrrolate; Humans; Muscarinic Antagonists; Network Meta-Analysis; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Salmeterol Xinafoate; Tiotropium Bromide; Treatment Outcome	2022
Ten years of tiotropium: clinical impact and patient perspectives. International journal of chronic obstructive pulmonary disease, 2013, Volume: 8 Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Bronchodilator Agents; Dyspnea; Ethanolamines; Formoterol Fumarate; Humans; Indans; Medication Adherence; Mucociliary Clearance; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide	2013
Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis. International journal of chronic obstructive pulmonary disease, 2015, Volume: 10 Topics: Bronchodilator Agents; Drug Combinations; Drug Therapy, Combination; Dyspnea; Forced Expiratory Volume; Formoterol Fumarate; Glycopyrrolate; Humans; Indans; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Tiotropium Bromide; Treatment Outcome	2015
Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use. Respiratory medicine, 2013, Volume: 107, Issue:2 Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspnea; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Glucocorticoids; Humans; Indans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Scopolamine Derivatives; Severity of Illness Index; Tiotropium Bromide; Treatment Outcome; Vital Capacity	2013
[Dyspnea and quality of life in chronic obstructive pulmonary disease]. Archivos de bronconeumologia, 2002, Volume: 38, Issue:10 Topics: Albuterol; Bronchodilator Agents; Clinical Trials as Topic; Dyspnea; Emotions; Exercise; Follow-Up Studies; Forced Expiratory Volume; Health Status; Humans; Interviews as Topic; Ipratropium; Multivariate Analysis; Placebos; Pulmonary Disease, Chronic Obstructive; Quality of Life; Salmeterol Xinafoate; Scopolamine Derivatives; Surveys and Questionnaires; Time Factors; Tiotropium Bromide	2002
[The beta2-adrenergic receptor agonists in the treatment of chronic obstructive pulmonary disease]. Przeglad lekarski, 2005, Volume: 62, Issue:7 Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Delayed-Action Preparations; Dyspnea; Ethanolamines; Formoterol Fumarate; Humans; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate	2005
Improving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategies. Proceedings of the American Thoracic Society, 2006, Volume: 3, Issue:3 Topics: Adrenergic beta-Agonists; Albuterol; Cholinergic Antagonists; Dyspnea; Humans; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Respiratory Function Tests; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome	2006
The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. The American journal of medicine, 2006, Volume: 119, Issue:10 Suppl 1 Topics: Acute Disease; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Dyspnea; Female; Fluticasone; Forced Expiratory Volume; Health Status; Humans; Male; Middle Aged; Patient Admission; Patient-Centered Care; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Risk Factors; Salmeterol Xinafoate; Scopolamine Derivatives; Severity of Illness Index; Tiotropium Bromide; Treatment Outcome	2006

Trials

22 trial(s) available for salmeterol xinafoate and Dyspnea

Article	Year
Perception of bronchoconstriction: a complementary disease marker in children with asthma. The Journal of asthma : official journal of the Association for the Care of Asthma, 2013, Volume: 50, Issue:6 Topics: Adolescent; Albuterol; Androstadienes; Anti-Allergic Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Child; Dyspnea; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Perception; Salmeterol Xinafoate	2013
Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD. Pulmonary pharmacology & therapeutics, 2014, Volume: 28, Issue:2 Topics: Administration, Oral; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Delayed-Action Preparations; Double-Blind Method; Dyspnea; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Inspiratory Capacity; Male; Middle Aged; Prednisolone; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Scopolamine Derivatives; Surveys and Questionnaires; Time Factors; Tiotropium Bromide	2014
Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: a pilot study. Respiratory medicine, 2010, Volume: 104, Issue:3 Topics: Aged; Albuterol; Androstadienes; Bronchodilator Agents; Combined Modality Therapy; Drug Administration Schedule; Drug Synergism; Dyspnea; Exercise Tolerance; Female; Fluticasone; Humans; Male; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome	2010
Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms. Respiratory medicine, 2010, Volume: 104, Issue:7 Topics: Adult; Airway Obstruction; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Dyspnea; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Spirometry; Tiotropium Bromide; Treatment Outcome	2010
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison. The European respiratory journal, 2011, Volume: 37, Issue:2 Topics: Adrenal Cortex Hormones; Aged; Albuterol; Bronchodilator Agents; Drug Administration Schedule; Dyspnea; Female; Health Status; Humans; Indans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Respiratory Function Tests; Salmeterol Xinafoate; Smoking; Surveys and Questionnaires	2011
Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD. Respiratory medicine, 2011, Volume: 105, Issue:6 Topics: Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Double-Blind Method; Dyspnea; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Health Status; Humans; Indans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Salmeterol Xinafoate	2011
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. The European respiratory journal, 2003, Volume: 21, Issue:1 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Dyspnea; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Male; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Time Factors; Vital Capacity	2003
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax, 2003, Volume: 58, Issue:5 Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Double-Blind Method; Dyspnea; Female; Forced Expiratory Volume; Hospitalization; Humans; Male; Metered Dose Inhalers; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Vital Capacity	2003
A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD. Treatments in respiratory medicine, 2004, Volume: 3, Issue:3 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Dyspnea; Female; Fluticasone; Humans; Ipratropium; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Time Factors; Treatment Outcome	2004
Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction. Respiratory medicine, 2004, Volume: 98, Issue:9 Topics: Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Dyspnea; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Male; Methacholine Chloride; Nebulizers and Vaporizers; Salmeterol Xinafoate; Time Factors	2004
Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease. Thorax, 2005, Volume: 60, Issue:4 Topics: Administration, Inhalation; Albuterol; Analysis of Variance; Androstadienes; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Dyspnea; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Treatment Outcome; Vital Capacity	2005
Addition of salmeterol to existing treatment in patients with COPD: a 12 month study. Thorax, 2006, Volume: 61, Issue:2 Topics: Albuterol; Bronchodilator Agents; Double-Blind Method; Dyspnea; Exercise Tolerance; Female; Forced Expiratory Volume; Health Status; Humans; Lung Volume Measurements; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Vital Capacity	2006
Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination. Pulmonary pharmacology & therapeutics, 2006, Volume: 19, Issue:6 Topics: Aged; Albuterol; Androstadienes; Anticoagulants; Blood Gas Analysis; Bronchodilator Agents; Double-Blind Method; Drug Therapy, Combination; Dyspnea; Enoxaparin; Female; Fluticasone; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Vital Capacity	2006
Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest, 2006, Volume: 130, Issue:3 Topics: Adrenergic beta-Agonists; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Dyspnea; Female; Fluticasone-Salmeterol Drug Combination; Humans; Lung; Lung Volume Measurements; Male; Middle Aged; Physical Endurance; Pulmonary Disease, Chronic Obstructive; Pulmonary Ventilation; Respiratory Function Tests; Respiratory Mechanics; Salmeterol Xinafoate; Tidal Volume; Time Factors	2006
Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. Clinical therapeutics, 2007, Volume: 29, Issue:2 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Male; Metered Dose Inhalers; Middle Aged; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Severity of Illness Index; Spirometry; Treatment Outcome	2007
Endurance shuttle walking test: responsiveness to salmeterol in COPD. The European respiratory journal, 2008, Volume: 31, Issue:3 Topics: Aged; Albuterol; Bronchodilator Agents; Cohort Studies; Cross-Over Studies; Double-Blind Method; Dyspnea; Exercise Test; Exercise Tolerance; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Vital Capacity	2008
Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD. Respiration; international review of thoracic diseases, 2008, Volume: 76, Issue:1 Topics: Administration, Inhalation; Aged; Albuterol; alpha 1-Antitrypsin Deficiency; Beclomethasone; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Dyspnea; Exercise Tolerance; Female; Glucocorticoids; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Scopolamine Derivatives	2008
Salmeterol reduces dyspnea and improves lung function in patients with COPD. Chest, 1997, Volume: 112, Issue:2 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Dyspnea; Humans; Lung Diseases, Obstructive; Salmeterol Xinafoate; Spirometry; Time Factors	1997
[Evaluation of the effectiveness and safety of salmeterol in children with nocturnal dyspnea]. Pneumonologia i alergologia polska, 1997, Volume: 65 Suppl 1 Topics: Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Child; Drug Administration Schedule; Dyspnea; Female; Humans; Male; Prednisone; Respiratory Function Tests; Salmeterol Xinafoate; Sleep Wake Disorders; Treatment Outcome	1997
The cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea in patients with advanced COPD. Chest, 2000, Volume: 118, Issue:3 Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Delayed-Action Preparations; Dyspnea; Exercise Therapy; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Physical Endurance; Respiratory Function Tests; Respiratory Muscles; Salmeterol Xinafoate; Severity of Illness Index	2000
Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD. The European respiratory journal, 2001, Volume: 17, Issue:6 Topics: Administration, Inhalation; Aged; Albuterol; Double-Blind Method; Dyspnea; Exercise Test; Female; Forced Expiratory Volume; Humans; Ipratropium; Male; Middle Aged; Salmeterol Xinafoate	2001
Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists. The European respiratory journal, 2001, Volume: 18, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dyspnea; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Male; Middle Aged; Salmeterol Xinafoate	2001

Other Studies

9 other study(ies) available for salmeterol xinafoate and Dyspnea

Article	Year
Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis. Respiratory medicine, 2017, Volume: 128 Topics: Adrenergic beta-2 Receptor Agonists; Aged; Aged, 80 and over; Bronchodilator Agents; Clinical Trials, Phase III as Topic; Double-Blind Method; Dyspnea; Female; Forced Expiratory Volume; Formoterol Fumarate; Health Status; Humans; Indans; Male; Middle Aged; Netherlands; Prevalence; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Severity of Illness Index; Smoking; Tiotropium Bromide; Treatment Outcome; Vital Capacity	2017
A retrospective study of Yiqibushenhuoxue decoction for the treatment of chronic obstructive pulmonary disease. Medicine, 2018, Volume: 97, Issue:31 Topics: Adult; Aged; Bronchodilator Agents; Drugs, Chinese Herbal; Dyspnea; Exercise Tolerance; Female; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory Function Tests; Retrospective Studies; Salmeterol Xinafoate; Treatment Outcome; Vital Capacity; Walk Test; Young Adult	2018
Dyspnoea worsened by salmeterol. Journal of the Royal Society of Medicine, 2002, Volume: 95, Issue:11 Topics: Adenocarcinoma; Albuterol; Asthma; Breast Neoplasms; Bronchodilator Agents; Diagnosis, Differential; Dyspnea; Female; Humans; Lung Neoplasms; Middle Aged; Salmeterol Xinafoate	2002
Minimal important difference of the transition dyspnoea index in a multinational clinical trial. The European respiratory journal, 2003, Volume: 21, Issue:2 Topics: Albuterol; Bronchodilator Agents; Cohort Studies; Double-Blind Method; Dyspnea; Female; Humans; Internationality; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Salmeterol Xinafoate; Scopolamine Derivatives; Severity of Illness Index; Tiotropium Bromide	2003
[The effect of time on the perception of dyspnea following inhaled long-acting bronchodilator]. Harefuah, 2003, Volume: 142, Issue:5 Topics: Administration, Inhalation; Albuterol; Asthma; Bronchodilator Agents; Dyspnea; Forced Expiratory Volume; Humans; Perception; Placebos; Salmeterol Xinafoate; Time Factors	2003
[Efficacy of bronchodilators: searching for objective criteria]. Revue de pneumologie clinique, 2003, Volume: 59, Issue:2 Pt 2 Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Dyspnea; Exercise; Follow-Up Studies; Functional Residual Capacity; Humans; Hyperventilation; Placebos; Plethysmography; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory Function Tests; Salmeterol Xinafoate; Spirometry; Time Factors; Total Lung Capacity	2003
Breathlessness during exercise in COPD: how do the drugs work? Thorax, 2004, Volume: 59, Issue:6 Topics: Albuterol; Bronchodilator Agents; Dyspnea; Exercise; Humans; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate	2004
Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids. International journal of chronic obstructive pulmonary disease, 2007, Volume: 2, Issue:2 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Albuterol; Bronchodilator Agents; Cholinergic Antagonists; Drug Therapy, Combination; Dyspnea; Forced Expiratory Volume; Health Status; Humans; Lung; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Retrospective Studies; Salmeterol Xinafoate; Scopolamine Derivatives; Time Factors; Tiotropium Bromide; Treatment Outcome	2007
[Evaluation of bronchial obstruction. Dyspnea, the quality of life]. Revue des maladies respiratoires, 1998, Volume: 15 Suppl 2 Topics: Activities of Daily Living; Albuterol; Attitude to Health; Bronchi; Bronchodilator Agents; Dyspnea; Forced Expiratory Volume; Health Status; Humans; Lung Diseases, Obstructive; Prognosis; Quality of Life; Salmeterol Xinafoate; Surveys and Questionnaires	1998